Professional
Added to YB: 2024-09-18
Pitch date: 2024-09-16
SRT.F [bullish]
Sartorius Aktiengesellschaft
+2.81%
current return
Author Info
No bio for this author
Company Info
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products.
Market Cap
EUR 14.5B
Pitch Price
EUR 184.81
Price Target
N/A
Dividend
0.31%
EV/EBITDA
20.60
P/E
N/A
EV/Sales
5.45
Sector
Life Sciences Tools and Services
Category
turnaround
RGA Investment Advisors Portfolio Holding: Sartorius Aktiengesellschaft
SRT.F: Bioprocessing firm facing challenges meeting guidance, leading to share price decline. Post-COVID bottom established, industry inflection point begun. Debate over return to normalized growth, but structural growth unchanged. Long-term returns from cost basis expected to meet or exceed initial projections.
Read full article (1 min)